Interventions for reducing benzodiazepine use in older people: Meta-analysis of randomised controlled trials

British Journal of Psychiatry

Volumn 204, Issue 2, 2014, Pages 98-107

  Gould, Rebecca L ^a   Coulson, Mark C ^b   Patel, Natasha ^a   Highton Williamson, Elizabeth ^a   Howard, Robert J ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b MIDDLESEX UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE; PLACEBO;

DRUG WITHDRAWAL; GERIATRIC PATIENT; GERONTOPSYCHIATRY; HUMAN; META ANALYSIS; PRESCRIPTION; PSYCHOPHARMACOTHERAPY; PSYCHOTHERAPY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SYSTEMATIC REVIEW; TREATMENT WITHDRAWAL;

AGE FACTORS; AGED; ANTI-ANXIETY AGENTS; BENZODIAZEPINES; BIAS (EPIDEMIOLOGY); COMBINED MODALITY THERAPY; DRUG ADMINISTRATION SCHEDULE; DRUG UTILIZATION; HUMANS; ODDS RATIO; PLACEBOS; PSYCHOTHERAPY; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REGRESSION ANALYSIS; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 84893521671     PISSN: 00071250     EISSN: 14721465     Source Type: Journal    
DOI: 10.1192/bjp.bp.113.126003     Document Type: Review

References (87)

1. Beers MH, Ouslander JG, Rollingher I, Reuben DB, Brooks J, Beck JC. Explicit criteria for determining inappropriate medication use in nursing-home residents. Arch Intern Med 1991; 151: 1825-32.
2. Fick DM, Cooper JW, Wade WE, Waller JL, Maclean JR, Beers MH. Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. Arch Intern Med 2003; 163: 2716-24.
3. Ashton CH. The Ashton Manual. Benzodiazepines: How They Work and How to Withdraw. 2002. http://www.benzo.org.uk/manual/.
4. Department of Health. Benzodiazepines warning. In Chief Medical Officer's Update 37, Patient Safety. Department of Health, 2004.
5. Buffett-Jerrott SE, Stewart SH. Cognitive and sedative effects of benzodiazepine use. Curr Pharm Des 2002; 8: 45-58.
6. Hill KD, Wee R. Psychotropic drug-induced falls in older people: a review of interventions aimed at reducing the problem. Drugs Aging 2012; 29: 15-30.
7. Cumming RG, Le Couteur DG. Benzodiazepines and risk of hip fractures in older people: a review of the evidence. CNS Drugs 2003; 17: 825-37.
8. Meuleners LB, Duke J, Lee AH, Palamara P, Hildebrand J, Ng JQ. Psychoactive medications and crash involvement requiring hospitalization for older drivers: a population-based study. J Am Geriatr Soc 2011; 59: 1575-80.
9. Clegg A, Young JB. Which medications to avoid in people at risk of delirium: a systematic review. Age Ageing 2011; 40: 23-9.
10. Voyer P, Preville M, Martin LS, Roussel ME, Beland SG, Berbiche D. Factors associated with self-rated benzodiazepine addiction among community-dwelling seniors. J Addict Nurs 2011; 22: 46-56.
11. American Geriatrics Society Beers Criteria Update Expert Panel. American Geriatrics Society updated Beers Criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc 2012; 60: 616-31.
12. Johnell K, Fastbom J. The use of benzodiazepines and related drugs amongst older people in Sweden: associated factors and concomitant use of other psychotropics. Int J Geriatr Psychiatry 2009; 24: 731-8.
13. Dionne PA, Vasiliadis HM, Latimer E, Berbiche D, Preville M. Economic impact of inappropriate benzodiazepine prescribing and related drug interactions among elderly persons. Psychiatr Serv 2013; 64: 331-8.
14. Martinsson G, Fagerberg I, Wiklund-Gustin L, Lindholm C. Specialist prescribing of psychotropic drugs to older persons in Sweden - a register-based study of 188 024 older persons. BMC Psychiatry 2012; 12: 197.
15. Preville M, Vasiliadis HM, Bosse C, Dionne PA, Voyer P, Brassard J, et al. Pattern of psychotropic drug use among older adults having a depression or an anxiety disorder: Results from the longitudinal ESA study. Can J Psychiatry 2011; 56: 348-57.
16. Lasserre A, Younes N, Blanchon T, Cantegreil-Kallen I, Passerieux C, Thomas G, et al. Psychotropic drug use among older people in general practice: discrepancies between opinion and practice. Br J Gen Pract 2010; 60: 156-62.
17. Russell J, Lader M. Guidelines for the Prevention and Treatment of Benzodiazepine Dependence. Mental Health Foundation, 1993.
18. Parr JM, Kavanagh DJ, Cahill L, Mitchell G, Young RM. Effectiveness of current treatment approaches for benzodiazepine discontinuation: a meta-analysis. Addiction 2008; 104: 13-24.
19. Mugunthan K, McGuire T, Glasziou P. Minimal interventions to decrease long-term use of benzodiazepines in primary care: a systematic review and meta-analysis. Br J Gen Pract 2011; 61: 573-8.
20. Oude Voshaar RC, Couvée JE, Van Balkom AJLM, Mulder PGH, Zitman FG. Strategies for discontinuing long-term benzodiazepine use. Meta-analysis. Br J Psychiatry 2006; 189: 213-20.
21. Denis C, Fatseas M, Lavie E, Auriacombe M. Pharmacological interventions for benzodiazepine mono-dependence management in outpatient settings. Cochrane Database Syst Rev 2006; 3: CD005194.
22. Milton JC, Hill-Smith I, Jackson SHD. Prescribing for older people. BMJ 2008; 336: 606-9.
23. Forsetlund L, Eike MC, Gjerberg E, Vist GE. Effect of interventions to reduce potentially inappropriate use of drugs in nursing homes: a systematic review of randomised controlled trials. BMC Geriatr 2011; 11: 16.
24. Nishtala PS, McLachlan AJ, Bell JS, Chen TF. Psychotropic prescribing in long-term care facilities: impact of medication reviews and educational interventions. Am J Geriatr Psychiatry 2008; 16: 621-32.
25. Smith AJ, Tett SE. Improving the use of benzodiazepines - is it possible? A non-systematic review of interventions tried in the last 20 years. BMC Health Serv Res 2010; 10: 321.
26. Marcum ZA, Handler SM, Wright R, Hanlon JT. Interventions to improve suboptimal prescribing in nursing homes: a narrative review. Am J Geriatr Pharmacother 2010; 8: 183-200.
27. Ostini R, Jackson C, Hegney D, Tett SE. How is medication prescribing ceased? A systematic review. Med Care 2011; 49: 24-36.
28. Cantopher T, Olivieri S, Cleave N, Edwards JG. Chronic benzodiazepine dependence. A comparative study of abrupt withdrawal under propranolol cover versus gradual withdrawal. Br J Psychiatry 1990; 156: 406-11.
29. Cormack MA, Sweeney KG, Hughesjones H, Foot GA. Evaluation of an easy, cost-effective strategy for cutting benzodiazepine use in general practice. Br J Gen Pract 1994; 44: 5-8.
30. Schweizer E, Rickels K, De Martinis N, Case G, Garcia-Espana F. The effect of personality on withdrawal severity and taper outcome in benzodiazepine dependent patients. Psychol Med 1998; 28: 713-20.
31. Schweizer E, Case WG, Rickels K. Benzodiazepine dependence and withdrawal in elderly patients. Am J Psychiatry 1989; 146: 529-31.
32. Ashton H. Benzodiazepine withdrawal - outcome in 50 patients. Br J Addict 1987; 82: 665-71.
33. Holden JD, Hughes IM, Tree A. Benzodiazepine prescribing and withdrawal for 3234 patients in 15 general practices. Fam Pract 1994; 11: 358-62.
34. Lemoine P, Kermadi I, Garcia-Acosta S, Garay RP, Dib M. Double-blind, comparative study of cyamemazine vs. bromazepam in the benzodiazepine withdrawal syndrome. Prog Neuropsychopharmacol Biol Psychiatry 2006; 30: 131-7.
35. Rickels K, Case WG, Schweizer E, Garciaespana F, Fridman R. Long-term benzodiazepine users 3 years after participation in a discontinuation program. Am J Psychiatry 1991; 148: 757-61.
36. Gorgels W, Oude Voshaar RC, Mol AJJ, van de Lisdonk EH, van Balkom A, Breteler MHM, et al. Predictors of discontinuation of benzodiazepine prescription after sending a letter to long-term benzodiazepine users in family practice. Fam Pract 2006; 23: 65-72.
37. Oude Voshaar RC, Gorgels WJMJ, Mol AJJ, Van Balkom AJLM, Van de Lisdonk EH, Breteler MHM, et al. Tapering off long-term benzodiazepine use with or without group cognitive-behavioural therapy: three-condition, randomised controlled trial. Br J Psychiatry 2003; 182: 498-504.
38. Schweizer E, Rickels K, Case WG, Greenblatt DJ. Long-term therapeutic use of benzodiazepines II. Effects of gradual taper. Arch Gen Psychiatry 1990; 47: 908-15.
39. Smith DH, Christensen DB, Stergachis A, Holmes G. A randomized controlled trial of a drug use review intervention for sedative hypnotic medications. Med Care 1998; 36: 1013-21.
40. Stewart R, Niessen WJM, Broer J, Snijders TAB, Haaijer-Ruskamp FM, Jong BMD. General practitioners reduced benzodiazepine prescriptions in an intervention study: a multilevel application. J Clin Epidemiol 2007; 60: 1076-84.
41. Ten Wolde GB, Dijkstra A, Van Empelen P, van den Hout W, Neven AK, Zitman F. Long-term effectiveness of computer-generated tailored patient education on benzodiazepines: a randomized controlled trial. Addiction 2008; 103: 662-70.
42. Tyrer P, Owen R, Dawling S. Gradual withdrawal of diazepam after long-term therapy. Lancet 1983; 1: 1402-6.
43. Foy A, Drinkwater V, March S, Mearrick P. Confusion after admission to hospital in elderly patients using benzodiazepines. BMJ 1986; 293: 1072.
44. Cormack MA, Sinnott A. Psychological alternatives to long-term benzodiazepine use. J R Coll Gen Pract 1983; 33: 279-81.
45. Covin R, Ouimet AJ, Seeds PM, Dozois DJ. A meta-analysis of CBT for pathological worry among clients with GAD. J Anxiety Disord 2008; 22: 108-16.
46. Department of Health. National Service Framework for Older People. Department of Health, 2001.
47. United Nations. World Economic and Social Survey. UN, 2007 (http://www.un.org/esa/policy/wess/wess2007files/chap1.pdf).
48. Woods JH, Katz JL, Winger GD. Benzodiazepines: use, abuse, and consequences. Pharmacol Rev 1992; 44: 151-347.
49. Higgins JPT, Altman DG, Sterne JAC. Chapter 8: Assessing risk of bias in included studies. In Cochrane Handbook for Systematic Reviews of Interventions (Version 5.1.0) (eds JPT Higgins, S Green). The Cochrane Collaboration, 2011.
50. Higgins JPT, Green S. Cochrane Handbook for Systematic Reviews of Interventions, version 5.1.0. Cochrane Collaboration, 2011 (http://www.cochrane- handbook.org).
51. Donner A, Klar N. Issues in the meta-analysis of cluster randomized trials. Stat Med 2002; 21: 2971-80.
52. Elbourne DR, Altman DG, Higgins JPT, Curtin F, Worthington HV, Vail A. Metaanalyses involving cross-over trials: methodological issues. Int J Epidemiol 2002; 31: 140-9.
53. StataCorp. Stata Statistical Software: Release 11.2. StataCorp, 2011.
54. Cochrane Collaboration. Review Manager (RevMan) [computer program]. Version 5.1. Nordic Cochrane Centre, Cochrane Collaboration, 2012.
55. Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003; 327: 557-60.
56. Riley RD, Higgins JPT, Deeks JJ. Interpretation of random effects metaanalyses. BMJ 2011; 342: 549.
57. Egger M, Smith GD, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315: 629-34.
58. Duval S, Tweedie R. Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics 2000; 56: 455-63.
59. Borenstein M, Hedges LV, Higgins JPT, Rothstein HR. Introduction to Meta-Analysis. Wiley, 2009.
60. Nakanishi Y, Toyoizumi S, Nakajima A, Hamada C. Subgroup analysis in meta-analysis: a comparison of different methods. Jpn J Pharmacoepidemiol 2007; 12: 13-24.
61. Higgins JPT, Thompson SG. Controlling the risk of spurious findings from meta-regression. Stat Med 2004; 23: 1663-82.
62. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 2009; 339: 2535.
63. Baillargeon L, Landreville P, Verreault R, Beauchemin JP, Gregoire JP, Morin CM. Discontinuation of benzodiazepines among older insomniac adults treated with cognitive-behavioural therapy combined with gradual tapering: a randomized trial. CMAJ 2003; 169: 1015-20.
64. Cardinali DP, Gvozdenovich E, Kaplan MR, Fainstein I, Shifis HA, Lloret SP, et al. A double blind-placebo controlled study on melatonin efficacy to reduce anxiolytic benzodiazepine use in the elderly. Neuro Endocrinol Lett 2002; 23: 55-60.
65. Di Costanzo E, Rovea A. The prophylaxis of benzodiazepine withdrawal syndrome in the elderly: the effectiveness of carbamazepine. Double-blind study vs. placebo. Minerva Psichiatr 1992; 33: 301-4.
66. Giblin MJ, Clift AD. Sleep without drugs. J R Coll Gen Pract 1983; 33: 628-33.
67. Habraken H, Soenen K, Blondeel L, VanElsen J, Bourda J, Coppens E, et al. Gradual withdrawal from benzodiazepines in residents of homes for the elderly: experience and suggestions for future research. Eur J Clin Pharmacol 1997; 51: 355-8.
68. Morin CM, Bastien C, Guay B, Radouco-Thomas M, Leblanc J, Vallieres A. Randomized clinical trial of supervised tapering and cognitive behavior therapy to facilitate benzodiazepine discontinuation in older adults with chronic insomnia. Am J Psychiatry 2004; 161: 332-42.
69. Petrovic M, Pevernagie D, Mariman A, Van Maele G, Afschrift M. Fast withdrawal from benzodiazepines in geriatric inpatients: a randomised double-blind, placebo-controlled trial. Eur J Clin Pharmacol 2002; 57: 759-64.
70. Salonoja M, Salminen M, Aarnio P, Vahlberg T, Kivela SL. One-time counselling decreases the use of benzodiazepines and related drugs among community-dwelling older persons. Age Ageing 2010; 39: 313-9.
71. Tham TCK, Brown H, Taggart HM. Temazepam withdrawal in elderly hospitalized patients - a double-blind randomized trial comparing abrupt versus gradual withdrawal. Ir J Med Sci 1989; 158: 294-9.
72. Velert Vila J. Intervención Farmacéutica para la Adecuación de la Prescripción de Benzodiazepinas en Pacientes Mayores [Pharmaceutical Intervention for the Suitability of Benzodiazepine Prescription in Older Patients]. Cardinal Herrera University, 2011.
73. Velert Vila J, del Mar Velert Vila M, Salar Ibanez L, Avellana Zaragoza JA, Moreno Royo L. Adecuación de la utilización de benzodiazepinas en ancianos desde la oficina de farmacia. Un estudio de colaboración médicofarmacéutico [Suitability of the use of benzodiazepines prescribed by the pharmacist in the elderly. A doctor-pharmacist collaboration study]. Aten Primaria 2012; 44: 402-10.
74. Avorn J, Soumerai SB, Everitt DE, Rossdegnan D, Beers MH, Sherman D, et al. A randomized trial of a program to reduce the use of psychoactive drugs in nursing homes. N Engl J Med 1992; 327: 168-73.
75. Crotty M, Whitehead C, Rowett D, Halbert J, Weller D, Finucane P, et al. An outreach intervention to implement evidence based practice in residential care: a randomized controlled trial. BMC Health Serv Res 2004; 4: 6.
76. Pit SW, Byles JE, Henry DA, Holt L, Hansen V, Bowman DA. A Quality Use of Medicines program for general practitioners and older people: a cluster randomised controlled trial. Med J Aust 2007; 187: 23-30.
77. Rikala M, Korhonen MJ, Sulkava R, Hartikainen S. The effects of medication assessment on psychotropic drug use in the community-dwelling elderly. Int Psychogeriatr 2011; 23: 473-84.
78. Roberts MS, Stokes JA, King MA, Lynne TA, Purdie DM, Glasziou PP, et al. Outcomes of a randomized controlled trial of a clinical pharmacy intervention in 52 nursing homes. Br J Clin Pharmacol 2001; 51: 257-65.
79. Strikwerda P, Bootsma-de Langen AM, Berghuis F, Meyboom-de Jong B. Drug therapy in a nursing home; favorable effect of feedback by the pharmacist on family physician's prescribing behavior. Ned Tijdschr Geneeskd 1994; 138: 1770-4.
80. Oborne CA, Hooper R, Swift CG, Jackson SHD. Explicit, evidence-based criteria to assess the quality of prescribing to elderly nursing home residents. Age Ageing 2003; 32: 102-8.
81. Thompson SG, Higgins JPT. How should meta-regression analyses be undertaken and interpreted? Stat Med 2002; 21: 1559-73.
82. Voyer P, Preville M, Cohen D, Berbiche D, Beland SG. The prevalence of benzodiazepine dependence among community-dwelling older adult users in Quebec according to typical and atypical criteria. Can J Aging 2010; 29: 205-13.
83. Oude Voshaar RC, Gorgels WJMJ, Mol AJJ, Van Balkom AJLM, Mulder J, Van de Lisdonk EH, et al. Long-term outcome of two forms of randomised benzodiazepine discontinuation. Br J Psychiatry 2006; 188: 188-9.
84. Dell'osso B, Lader M. Do benzodiazepines still deserve a major role in the treatment of psychiatric disorders? A critical reappraisal. Eur Psychiatry 2013; 28: 7-20.
85. Lader M, Tylee A, Donoghue J. Withdrawing benzodiazepines in primary care. CNS Drugs 2009; 23: 19-34.
86. Oude Voshaar RC, Krabbe PFM, Gorgels WJMJ, Adang EM, van Balkom AJ, van de Lisdonk EH, et al. Tapering off benzodiazepines in long-term users: an economic evaluation. Pharmacoeconomics 2006; 24: 683-94.
87. Ostini R, Hegney D, Jackson C, Tett SE. Knowing how to stop: ceasing prescribing when the medicine is no longer required. J Manag Care Pharm 2012; 18: 68-72.